Article Text
Therapeutics
Randomised controlled trial
Naltrexone–buproprion causes weight loss in overweight and obese adults
Statistics from Altmetric.com
Footnotes
-
Competing interests SRS has been reimbursed as a consultant ore received research support from by Arena, Amylin, BMS, Jenrin Discoveries Zafgen, Takeda. SRS has also conducted research for, and served as a consultant to, Orexigen pharmaceuticals who sponsored the reviewed paper.